>Рынок наборов для домашнего тестирования в Северной Америке по типу теста (тест на беременность, набор для тестирования на ВИЧ , диабет, инфекционные заболевания, тесты на глюкозу, набор для прогнозирования овуляции, набор для тестирования на злоупотребление наркотиками и другие), типу (кассета, полоска, мидстрим, тестовая панель, дип-карта и другие), возрасту (детский, взрослый и гериатрический), типу образца (моча, кровь, слюна и другие типы образцов), использованию (одноразовые и многоразовые), каналам сбыта (розничные аптеки, аптеки, супермаркеты/гипермаркеты и интернет-аптеки) — тенденции отрасли и прогноз до 2029 года.
Анализ и аналитика рынка наборов для домашнего тестирования в Северной Америке
Ожидается, что рынок наборов для домашнего тестирования в Северной Америке будет расти, так как раньше люди часто посещали больницы, даже с простыми проблемами, но из-за растущей осведомленности о нескольких продуктах это поведение изменилось и изменило тенденцию. Наборы для домашнего или самостоятельного тестирования легко доступны в аптеках, и их стало чрезвычайно легко приобрести. Различные медицинские компании выходят на эту сферу, поскольку они быстро производят наборы для самостоятельного тестирования.
Такая широкая доступность также может быть связана с медицинскими стартапами интернет-аптек, которые упрощают доступность нажатием кнопки. Кроме того, эти наборы для самостоятельного тестирования доступны без рецепта, что может легко стимулировать рынок наборов для домашнего тестирования. Наборы для домашнего тестирования позволяют конечным пользователям собирать образцы дома, а затем либо проводить тесты дома, либо отправлять эти образцы в лабораторию для тестирования. Наборы для домашнего тестирования, несомненно, упростили процесс подтверждения беспокойства человека, будь то домашний тест на беременность или тест на ВИЧ или любые другие инфекционные заболевания.
Эти наборы для домашнего тестирования просты в использовании и также доступны по цене. Однако всегда есть сомнения относительно точности результатов, что стало сдерживающим фактором для рынка наборов для домашнего тестирования в Северной Америке. Ложноположительный результат теста может вызвать у человека беспокойство и стресс, даже если у него его нет. Получение ложноположительных или отрицательных результатов очень расстраивает и беспокоит человека. Сегодня многие компании производят наборы для быстрой диагностики COVID-19, которые можно проводить дома. Но существуют различные проблемы, связанные с точностью, из-за которых распространение этих наборов для домашнего тестирования было приостановлено из-за проверки их надежности.
По данным исследования рынка Data Bridge, среднегодовой темп роста рынка наборов для домашнего тестирования в Северной Америке составит 6,3% в прогнозируемый период с 2022 по 2029 год.
Отчет Метрика |
Подробности |
Прогнозируемый период |
2022-2029 |
Базовый год |
2021 |
Исторические годы |
2020 (Можно настроить на 2019-2014) |
Количественные единицы |
Доход в млн. долл. США, цены в долл. США |
Охваченные сегменты |
By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Others), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies) |
Countries Covered |
U.S., Canada and Mexico |
Market Players Covered |
Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, BD, Drägerwerk AG & Co. KGaA, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG., Nectar Lifesciences Ltd. (Rapikit), ACON Laboratories, Inc., Quidel Corporation., ARKRAY USA, Inc., BTNX INC., Atomo Diagnostics, Eurofins Scientific, Piramal Enterprises Ltd., Bionime Corporation., Nova Biomedical, Cardinal Health., OraSure Technologies, Biolytical Laboratories Inc., Everlywell, Inc., SA Scientific Ltd., Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH), Biosynex, PRIMA Lab SA, MP BIOMEDICALS., Sterilab Services, Chembio Diagnostics, Inc., BioSure, Selfdiagnostics OU among others |
North America At-Home Testing Kits Market Definition
At-home testing kits means testing instruments which help people to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide person through the steps of taking a test. Various at-home test kits are available including HIV tests, pregnancy test, diabetes, ovulation test, infectious diseases such as malaria, COVID-19 and others. For performing these rapid at-home tests blood, urine and oral fluid can be taken as a sample.
North America At-Home Testing Kits Market Dynamics
Drivers
- Growing adoption of self-testing kits
Earlier, people used to visit hospitals often, even for basic problems. However, as awareness has grown regarding several products, this behavior has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor.
This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals and patients as hospitals are already stretched thin and can entirely focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their tests' results at their fingertips.
- Easy availability of self-testing kits at pharmacies
At-home or self-testing kits are easily available at pharmacies, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.
This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.
Opportunity
- Advent of advanced technologies
The latest technologies are crucial in making medical products very advanced and reliable to trust. In different medical devices, Artificial Intelligence (AI) and Machine Learning (ML) are important aspects of the healthcare sector with the ability to enhance patient safety and administrative processes by work automation and quicker performance.
It is certain that, by default, AI-powered diagnostic instruments will continue to develop. AI has only taken modest moves into a huge and multi-dimensional opportunity in the healthcare sector.
Restraint/Challenge
- Inaccuracy of results by self-testing kits
At-home testing kits allow end-users to collect their specimen at home and perform the tests at home or send that specimen to the lab for testing. At-home testing kits have undoubtedly eased the process of confirming the person's concern, whether it is a home pregnancy test, HIV test, or any other infectious diseases test.
These at-home testing kits are easy to use and are affordable too. However, there is always a doubt about the accuracy of the results. COVID-19 home monitoring can be more comfortable than going to a hospital or doctor's office. It will also help reduce the risk of the coronavirus being spread or acquired when you are screened.
However, a false positive test result may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results. Today, many companies produce rapid diagnostic test kits for COVID-19 which can be performed at home, but there are various accuracy-related issues due to which the distribution of those at-home test kits has been suspended from verifying their reliability.
Post COVID-19 Impact on North America At-Home Testing Kits Market
COVID-19 created a great impact on the at home testing kits market. The market for at-home testing kits is expanding as a consequence of the increased popularity of self-help and Do-It-Yourself (DIY) test kits due to their convenience and quick results. Consumers have concerns about the dependability of rapid home testing kits, which could impede the market's expansion for at-home testing kits. Rapid testing kits for COVID-19 are now urgently needed by companies in order to reduce patient deaths and boost patient recovery rates and also increased rate for the at home testing kits market for Diabetic patients and patients having heart problems. This is creating a major market opportunity for at-home testing kits.
Recent Development
- In March 2022, LifeScan IP Holdings, LLC announced that the company’s product, OneTouch Verio Flex topped the Forbes Health Best Standard Glucose Meters based on price, affordable test strips, colour range indicator, small sample of blood and compact design. This had helped the company to increase their global presence in the market
North America At-Home Testing Kits Market Scope
North America at-home testing kits market is categorized into six notable segments based on test type, type, age, sample type, usage, and distribution channels. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Pregnancy Test
- HIV Test Kit
- Diabetes
- Infectious Diseases
- Glucose Tests
- Ovulation Predictor Test Kit
- Drug Abuse Test Kit
- Others
Based on test type, the North America at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit, and others.
Type
- Cassette
- Strip
- Midstream
- Test Panel
- Dip Card
- Others
Based on type, the North America at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card, and others.
Age
- Pediatric
- Adult
- Geriatric
Based on age, the North America at-home testing kits market is segmented into pediatric, adult, and geriatric.
Sample Type
- Urine
- Blood
- Saliva
- Others
Based on sample type, the North America at-home testing kits market is segmented into urine, blood, saliva, and others.
Usage
- Disposable
- Reusable
Based on usage, the North America at-home testing kits market is segmented into disposable and reusable.
Distribution Channels
- Retail Pharmacies
- Drug Store
- Supermarket/Hypermarket
- Online Pharmacies
Based on distribution channels, the North America at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies.
North America At-Home Testing Kits Market Regional Analysis/Insights
North America at-home testing kits market is analyzed and market size insights and trends are provided based on test type, type, age, sample type, usage and distribution channels.
Отчет о рынке наборов для домашнего тестирования в Северной Америке охватывает следующие регионы: США, Канада и Мексика.
США доминируют на рынке наборов для домашнего тестирования в Северной Америке с точки зрения доли рынка и доходов рынка и продолжат процветать в течение прогнозируемого периода. Это связано с высокими расходами страны на здравоохранение и растущей осведомленностью о рынке наборов для домашнего тестирования в Северной Америке.
Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Такие данные, как анализ цепочки создания стоимости вверх и вниз по течению, технические тенденции, анализ пяти сил Портера и тематические исследования, являются некоторыми из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, влияние внутренних тарифов и торговые пути.
Конкурентная среда и анализ доли рынка наборов для домашнего тестирования в Северной Америке
Конкурентная среда рынка наборов для домашнего тестирования в Северной Америке содержит подробную информацию по конкурентам. Включены следующие сведения: обзор компании, финансовые показатели компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, присутствие в Северной Америке, производственные площадки и объекты, сильные и слабые стороны компании, запуск продукта, клинические испытания, анализ бренда, одобрение продукта, патенты, широта и широта продукта, доминирование приложений, кривая жизненной линии технологий. Приведенные выше данные относятся только к фокусу компаний, связанному с рынком наборов для домашнего тестирования в Северной Америке.
Некоторые из основных игроков, работающих на рынке наборов для домашнего тестирования в Северной Америке, включают Abbott, ACON Laboratories, Inc., Rapikit, BD, Cardinal Health, B. Braun Melsungen AG, Piramal Enterprises Ltd., Siemens Healthcare GmbH, Quidel Corporation, Bionime Corporation, SA Scientific, ARKRAY USA, Inc., Nova Biomedical, AdvaCare Pharma, AccuBioTech Co., Ltd., Atlas Medical UK, TaiDoc Technology Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd, Sensing Self, PTE. Ltd, Atomo Diagnostics, RUNBIO BIOTECH CO., LTD., Mylan NV (дочерняя компания Viatris, Inc.), MP BIOMEDICALS, VedaLab, Shanghai Chemtron Biotech Co.Ltd. и Ascensia Diabetes Care Holdings AG, а также других отечественных игроков.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA AT-HOME TESTING KITS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE
2.8 MARKET POSITION COVERAGE GRID
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.1 DBMR MARKET POSITION GRID
2.11 DISTRIBUTOR CHANNEL ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 NORTH AMERICA AT- HOME TESTING KITS MARKET: REGULATIONS
5.1 REGULATION IN U.S
5.2 GUIDELINES FOR SELF-TESTING KITS
5.3 REGULATION IN EUROPE
5.4 GUIDELINES FOR TESTING KITS
5.5 REGULATION IN INDONESIA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING ADOPTION OF SELF-TESTING KITS
6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES
6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS
6.1.4 EASE OF USE AND LOW COSTS OF RAPID SELF-TEST KITS
6.2 RESTRAINTS
6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS
6.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS
6.3 OPPORTUNITIES
6.3.1 ADVENT OF ADVANCED TECHNOLOGIES
6.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS
6.4 CHALLENGES
6.4.1 HIGH COMPETITION IN THE MEDICAL TECHNOLOGY INDUSTRY
6.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS
7 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 GLUCOSE TESTS
7.3 INFECTIOUS DISEASES
7.4 PREGNANCY TEST
7.5 DRUG ABUSE TEST KITS
7.6 HIV TEST KIT
7.7 OVULATION PREDICTOR TEST KIT
7.8 OTHERS TEST TYPES
8 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE
8.1 OVERVIEW
8.2 CASSETTES
8.2.1 RETAIL PHARMACIES
8.2.2 ONLINE PHARMACIES
8.2.3 DRUG STORE
8.2.4 SUPERMARKET/HYPERMARKET
8.3 STRIP
8.3.1 RETAIL PHARMACIES
8.3.2 ONLINE PHARMACIES
8.3.3 DRUG STORE
8.3.4 SUPERMARKET/HYPERMARKET
8.4 MIDSTREAM
8.4.1 RETAIL PHARMACIES
8.4.2 ONLINE PHARMACIES
8.4.3 DRUG STORE
8.4.4 SUPERMARKET/HYPERMARKET
8.5 DIP CARD
8.5.1 RETAIL PHARMACIES
8.5.2 ONLINE PHARMACIES
8.5.3 DRUG STORE
8.5.4 SUPERMARKET/HYPERMARKET
8.6 TEST PANEL
8.6.1 RETAIL PHARMACIES
8.6.2 ONLINE PHARMACIES
8.6.3 DRUG STORE
8.6.4 SUPERMARKET/HYPERMARKET
8.7 OTHERS
9 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE
9.1 OVERVIEW
9.2 ADULT
9.3 GERIATRIC
9.4 PEDIATRIC
10 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 URINE
10.4 SALIVA
10.5 OTHER SAMPLE TYPES
11 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE
11.1 OVERVIEW
11.2 DISPOSABLE
11.3 REUSABLE
12 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS
12.1 OVERVIEW
12.2 RETAIL PHARMACIES
12.3 ONLINE PHARMACIES
12.4 DRUG STORE
12.5 SUPERMARKET/HYPERMARKET
13 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ABBOTT
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUS ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 SIEMENS HEALTHCARE GMBH
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUS ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENTS
16.3 F. HOFFMANN- LA ROCHE LTD
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 BD
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 DRÄGERWERK AG & CO. KGAA
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 LIFESCAN IP HOLDINGS, LLC
16.6.1 COMPANY SNAPSHOT
16.6.2 COMPANY SHARE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 ASCENSIA DIABETES CARE HOLDINGS AG.
16.7.1 COMPANY SNAPSHOT
16.7.2 COMPANY SHARE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 NECTAR LIFESCIENCES LTD. (RAPIKIT)
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 ACON LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 QUIDEL CORPORATION.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 ARKRAY USA, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 BTNX INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 ATOMO DIAGNOSTICS
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 EUROFINS SCIENTIFIC
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENTS
16.15 PIRAMAL ENTERPRISES LTD.
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 BIONIME CORPORATION
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 NOVA BIOMEDICAL
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 CARDINAL HEALTH.
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 ORASURE TECHNOLOGIES
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENTS
16.2 BIOLYTICAL LABORATORIES INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 EVERLYWELL, INC.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 SA SCIENTIFIC LTD.
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH)
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 BIOSYNEX
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENTS
16.25 PRIMA LAB SA
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENTS
16.26 MP BIOMEDICALS.
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
16.27 STERILAB SERVICES
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENTS
16.28 CHEMBIO DIAGNOSTICS, INC.
16.28.1 COMPANY SNAPSHOT
16.28.2 REVENUE ANALYSIS
16.28.3 PRODUCT PORTFOLIO
16.28.4 RECENT DEVELOPMENTS
16.29 BIOSURE
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENTS
16.3 SELFDIAGNOSTICS OU
16.30.1 COMPANY SNAPSHOT
16.30.2 PRODUCT PORTFOLIO
16.30.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Список таблиц
TABLE 1 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA GLUCOSE TESTS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA INFECTIOUS DISEASES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA DRUG ABUSE TEST KITS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA HIV TEST KIT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA OVULATION PREDICTOR TEST KIT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA OTHERS TEST TYPES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA STRIP IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA OTHERS IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA ADULT IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA GERIATRIC IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA PEDIATRIC IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA BLOOD IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA URINE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA SALIVA IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA OTHER SAMPLE TYPES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA DISPOSABLE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA REUSABLE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA RETAIL PHARMACIES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA ONLINE PHARMACIES IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA DRUG STORE IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA SUPERMARKET/HYPERMARKET IN AT-HOME TESTING KITS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 50 U.S. AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 51 U.S. AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 52 U.S. STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 53 U.S. CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 54 U.S. MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 55 U.S. DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 56 U.S. TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 57 U.S. AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 58 U.S. AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 59 U.S. AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 60 U.S. AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 61 CANADA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 62 CANADA AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 63 CANADA STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 64 CANADA CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 65 CANADA MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 66 CANADA DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 67 CANADA TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 68 CANADA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 69 CANADA AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 70 CANADA AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 71 CANADA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 72 MEXICO AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)
TABLE 73 MEXICO AT-HOME TESTING KITS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 74 MEXICO STRIPS IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 75 MEXICO CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 76 MEXICO MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 77 MEXICO DIP CARD IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 78 MEXICO TEST PANEL IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
TABLE 79 MEXICO AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (USD MILLION)
TABLE 80 MEXICO AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2020-2029 (USD MILLION)
TABLE 81 MEXICO AT-HOME TESTING KITS MARKET, BY USAGE, 2020-2029 (USD MILLION)
TABLE 82 MEXICO AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2020-2029 (USD MILLION)
Список рисунков
FIGURE 1 NORTH AMERICA AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA AT-HOME TESTING KITS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA AT-HOME TESTING KITS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA AT-HOME TESTING KITS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA AT-HOME TESTING KITS MARKET: MARKET POSITION COVERAGE GRID
FIGURE 7 NORTH AMERICA AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA AT-HOME TESTING KITS MARKET: DISTRIBUTOR CHANNEL ANALYSIS
FIGURE 10 NORTH AMERICA AT-HOME TESTING KITS MARKET: SEGMENTATION
FIGURE 11 GROWING ADOPTION OF SELF-TESTING KITS IS EXPECTED TO DRIVE NORTH AMERICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 GLUCOSE TEST IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NORTH AMERICA AT-HOME TESTING KITS MARKET, BY TEST TYPE IN 2022 & 2029
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS THE FASTEST GROWING REGION IN THE NORTH AMERICA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA AT-HOME TESTING KITS MARKET
FIGURE 15 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2021
FIGURE 16 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022-2029 (USD MILLION)
FIGURE 17 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2022-2029)
FIGURE 18 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, 2021
FIGURE 20 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, 2021
FIGURE 24 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, 2022-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2021
FIGURE 28 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2022-2029 (EURO MILLION)
FIGURE 29 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 31 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, 2021
FIGURE 32 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, 2022-2029 (EURO MILLION)
FIGURE 33 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE
FIGURE 35 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 36 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 37 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 38 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 39 NORTH AMERICA AT-HOME TESTING KITS MARKET: SNAPSHOT (2021)
FIGURE 40 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021)
FIGURE 41 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 NORTH AMERICA AT-HOME TESTING KITS MARKET: BY TEST TYPE (2022-2029)
FIGURE 44 NORTH AMERICA AT-HOME TESTING KITS MARKET: COMPANY SHARE 2021 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.